✦ LIBER ✦

Hepatocellular carcinoma: Sorafenib before liver transplantation?

✍ Scribed by Alain Braillon

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 495 KB
Volume: 51
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.23439

No coin nor oath required. For personal study only.

✦ Synopsis

This study was partially supported by grants UBACYT M055 (Universidad de Buenos Aires) and PICT 06-124 (Agencia Nacional de Promocio´n Cien-tı´fica y Tecnolo´gica).

📜 SIMILAR VOLUMES

Sorafenib therapy in patients with hepat

Sorafenib therapy in patients with hepatocellular carcinoma before liver transplantation

✍ Ian A. Rowe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 1 views

The team of Liu et al. generated endoderm-derived human induced pluripotent stem (iPS) cells from primary hepatocytes. 1 However, they generated human iPS cells by using viral transgenes. 1 Clinical applications of human iPS cells require avoiding viral transgenes. On the other hand, the reprogrammi

Use of sorafenib in patients with hepato

Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: A cost-benefit analysis while awaiting data on sorafenib safety

✍ Alessandro Vitale; Michael L. Volk; Davide Pastorelli; Sara Lonardi; Fabio Farin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB 👁 1 views

The role of bridging therapies for patients with hepatocellular carcinoma (HCC) on the waiting list for liver transplantation (LT) remains controversial. There is strong evidence to support the effectiveness of sorafenib in extending the time to progression of HCC. Using a Markov model, we compared

Accuracy of detecting hepatocellular car

Accuracy of detecting hepatocellular carcinomas before liver transplantation

✍ James D. Perkins 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Liver transplantation for hepatocellular

Liver transplantation for hepatocellular carcinoma

✍ C.-M. Lo; S.-T. Fan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 3 views

Liver transplantation for hepatocellular

Liver transplantation for hepatocellular carcinoma

✍ Alan P. Venook 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 1 views

Background: Liver transplantation for unresectable hepatocellular carcinoma yields disappointing results. Most cases recur within 2 years, often in the transplanted liver. Methods: A combination of neoadjuvant doxorubicin and orthotopic liver transplantation was used in 20 patients with unresectable

Neoadjuvant therapies for hepatocellular

Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: A critical appraisal

✍ Patricia M. Lopez; Augusto Villanueva; Sasan Roayaie; Josep M. Llovet 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Hepatocellular carcinoma (HCC) is a major health problem, being the fifth most common cancer worldwide. 1 The incidence of HCC is increasing in Europe and the United States, 2 and it is currently the leading cause of death among patients with cirrhosis. 3 The advent of surveillance programs has led